Maze Therapeutics, Inc.
NASDAQ:MAZE · NASDAQ Global Market
+$0.18 today
Vol 1.05M · Avg 0.84M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+139.33%
Period High
$51.84
Period Low
$10.33
Latest
$25.68
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Spyre Therapeutics, Inc.
NASDAQ:SYRE
$5.29B
Trevi Therapeutics, Inc.
NASDAQ:TRVI
$2.39B
Pharvaris N.V.
NASDAQ:PHVS
$2.28B
BioCryst Pharmaceuticals, Inc.
NASDAQ:BCRX
$1.90B
Immunome, Inc.
NASDAQ:IMNM
$1.73B
Intellia Therapeutics, Inc.
NASDAQ:NTLA
$1.69B
Zymeworks Inc.
NASDAQ:ZYME
$1.68B
Sionna Therapeutics, Inc.
NASDAQ:SION
$1.68B
Ardelyx, Inc.
NASDAQ:ARDX
$1.43B
Wave Life Sciences Ltd.
NASDAQ:WVE
$1.17B
What is the latest MAZE filing?
The latest filing shown is 4 dated Jun 10, 2026.
How many recent filings does MAZE have?
Intrinsic Alpha currently shows 20 recent filings for MAZE.
Explore More
Continue the stock analysis
Jump to another research area for this company.